These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38603308)

  • 1. Language models for the prediction of SARS-CoV-2 inhibitors.
    Blanchard AE; Gounley J; Bhowmik D; Chandra Shekar M; Lyngaas I; Gao S; Yin J; Tsaris A; Wang F; Glaser J
    Int J High Perform Comput Appl; 2022 Nov; 36(5-6):587-602. PubMed ID: 38603308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning.
    Santana MVS; Silva-Jr FP
    BMC Chem; 2021 Feb; 15(1):8. PubMed ID: 33531083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Pre-trained and Feature-Based Models for Prediction of Alzheimer's Disease Based on Speech.
    Balagopalan A; Eyre B; Robin J; Rudzicz F; Novikova J
    Front Aging Neurosci; 2021; 13():635945. PubMed ID: 33986655
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations.
    Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ
    Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Patient Populations in Texts Describing Drug Approvals Through Deep Learning-Based Information Extraction: Development of a Natural Language Processing Algorithm.
    Gendrin A; Souliotis L; Loudon-Griffiths J; Aggarwal R; Amoako D; Desouza G; Dimitrievska S; Metcalfe P; Louvet E; Sahni H
    JMIR Form Res; 2023 Jun; 7():e44876. PubMed ID: 37347514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening.
    Zhang LC; Zhao HL; Liu J; He L; Yu RL; Kang CM
    Future Med Chem; 2022 Mar; 14(6):393-405. PubMed ID: 35220726
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors.
    Ghosh K; Amin SA; Gayen S; Jha T
    J Mol Struct; 2021 Jan; 1224():129026. PubMed ID: 32834115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2.
    Santos LH; Kronenberger T; Almeida RG; Silva EB; Rocha REO; Oliveira JC; Barreto LV; Skinner D; Fajtová P; Giardini MA; Woodworth B; Bardine C; Lourenço AL; Craik CS; Poso A; Podust LM; McKerrow JH; Siqueira-Neto JL; O'Donoghue AJ; da Silva Júnior EN; Ferreira RS
    bioRxiv; 2022 Jan; ():. PubMed ID: 35018373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supervised fine-tuning of pre-trained antibody language models improves antigen specificity prediction.
    Wang M; Patsenker J; Li H; Kluger Y; Kleinstein SH
    bioRxiv; 2024 May; ():. PubMed ID: 38798340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg
    Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS
    J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging pre-trained language models for mining microbiome-disease relationships.
    Karkera N; Acharya S; Palaniappan SK
    BMC Bioinformatics; 2023 Jul; 24(1):290. PubMed ID: 37468830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-tuning BERT for automatic ADME semantic labeling in FDA drug labeling to enhance product-specific guidance assessment.
    Shi Y; Wang J; Ren P; ValizadehAslani T; Zhang Y; Hu M; Liang H
    J Biomed Inform; 2023 Feb; 138():104285. PubMed ID: 36632860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model.
    Hu F; Jiang J; Yin P
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Learning-Based Bioactive Therapeutic Peptide Generation and Screening.
    Zhang H; Saravanan KM; Wei Y; Jiao Y; Yang Y; Pan Y; Wu X; Zhang JZH
    J Chem Inf Model; 2023 Feb; 63(3):835-845. PubMed ID: 36724090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. srBERT: automatic article classification model for systematic review using BERT.
    Aum S; Choe S
    Syst Rev; 2021 Oct; 10(1):285. PubMed ID: 34717768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mpropred: A machine learning (ML) driven Web-App for bioactivity prediction of SARS-CoV-2 main protease (Mpro) antagonists.
    Ferdous N; Reza MN; Hossain MU; Mahmud S; Napis S; Chowdhury K; Mohiuddin AKM
    PLoS One; 2023; 18(6):e0287179. PubMed ID: 37352252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Natural Language Processing Model for COVID-19 Detection Based on Dutch General Practice Electronic Health Records by Using Bidirectional Encoder Representations From Transformers: Development and Validation Study.
    Homburg M; Meijer E; Berends M; Kupers T; Olde Hartman T; Muris J; de Schepper E; Velek P; Kuiper J; Berger M; Peters L
    J Med Internet Res; 2023 Oct; 25():e49944. PubMed ID: 37792444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy.
    Wu Y; Li K; Li M; Pu X; Guo Y
    J Chem Inf Model; 2023 Nov; 63(22):7011-7031. PubMed ID: 37960886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classifying the lifestyle status for Alzheimer's disease from clinical notes using deep learning with weak supervision.
    Shen Z; Schutte D; Yi Y; Bompelli A; Yu F; Wang Y; Zhang R
    BMC Med Inform Decis Mak; 2022 Jul; 22(Suppl 1):88. PubMed ID: 35799294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical Review of Plant-Derived Compounds as Possible Inhibitors of SARS-CoV-2 Proteases: A Comparison with Experimentally Validated Molecules.
    Guerra Y; Celi D; Cueva P; Perez-Castillo Y; Giampieri F; Alvarez-Suarez JM; Tejera E
    ACS Omega; 2022 Dec; 7(49):44542-44555. PubMed ID: 36530229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.